“…142 However, recent data suggest that this incidence may be stable in some other institutions. 143,144 The emergence of serious infections related to Candida glabrata and Candida krusei, which are mostly resistant to triazoles (fluconazole and itraconazole), was reported [145][146][147][148] by bone-marrow transplant centers and some ICUs, where the proportion of these strains may represent Ͼ 50% of isolates from colonized patients. However, no such evolution has been reported 23,149,150 in other institutions where the use of triazole prophylaxis was restricted to high-risk patients.…”